nintedanib
Active substance: nintedanib esylate
CAPSULE · NINTEDANIB ESYLATE 150 mg/1
United StatesActive
Marketing holder: AvKARE
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- NINTEDANIB ESYLATE · 150 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-5b9e-7f34-951e-55fd984a0918,01a1208c-5df2-7c28-ae5b-33c00ce96d4c,01a1208c-d00b-77e2-b009-a29f730c7550,01a1208d-17ea-7308-bc92-7bf05436f0b1,01a1208d-8f17-78b8-b30c-164777747d35;count=24 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 73190-097
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 73190-097 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 73190-097 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 73190-097 · Verified 2026-10-09 · open in source